Sandra Kostyk, MD, PhD
Appointments: (614) 293-4969
- Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2014, 2017
- Named to the Castle Connolly list of America’s “Top Doctors” for 2017
Specialties and Conditions I Treat
- Huntington Disease
- Parkinson's Disease
- Spinal Cord Injuries
Locations Where I Practice
Education and Training
University of Chicago, Pritzker School of Medicine
Massachusetts General Hospital
7/1/1986 - 6/30/1989
More About My Work
American Board of Physical Medicine & Rehabilitation (Subspecialty: Spinal Cord Injury)
American Board of Psychiatry & Neurology (Subspecialty: Neurology)
71 Patient Satisfaction Reviews
The overall patient satisfaction rating is an average of all patient responses to the six doctor communication related questions shown below from the Clinician and Group Consumer Assessment of Healthcare Providers and Systems survey. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page.
The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of Ohio State Wexner Medical Center.
4.9 out of 5
- Explains Things Clearly 4.9
- Listens Carefully 4.9
- Gives Understandable Instructions 4.9
- Knows My Medical History 4.9
- Shows Respect 4.9
- Time Spent Together 4.9
5 Patient Comments
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/28/2017, Dr. Kostyk has reported no financial relationships with medical device, research and/or drug companies.